Gastric epithelial neoplasm of fundic-gland mucosa lineage: representative of the low atypia differentiated gastric tumor and Ki67 may help in their identification

Houqiang Li, Lanqing Zheng, Guodong Zhong, Xunbin Yu, Xia Zhang, Linying Chen, X Y ChenPathology 2024 · DOI

Abstract

Gastric epithelial neoplasms of the fundic-gland mucosa lineage (GEN-FGMLs) are rare gastric tumors including oxyntic gland adenoma (OGA), gastric adenocarcinoma of the fundic-gland type (GA-FG), and gastric adenocarcinoma of the fundic-gland mucosa type (GA-FGM). Due to their low cellular atypia and similarity to normal gastric tissue, these tumors are frequently misdiagnosed. This study analyzed 37 cases to identify key clinicopathological features and diagnostic thresholds. Findings indicate that tumor size (>4.5 mm) and the Ki67 proliferation index (>2.5%) are critical for distinguishing between benign OGAs and low-grade adenocarcinomas (GA-FG/GA-FGM).

Introduction

In gastric oncology, most malignancies are characterized by high-grade atypia—cells that appear disorganized and clearly abnormal. However, Gastric Epithelial Neoplasms of Fundic-Gland Mucosa Lineage (GEN-FGMLs) represent a "low atypia" category of tumors that mimic the normal fundic glands of the stomach lining. This group includes Oxyntic Gland Adenomas (OGA), Gastric Adenocarcinoma of the Fundic-Gland type (GA-FG), and the rare Fundic-Gland Mucosa type (GA-FGM). The lack of global consensus on classification and their benign appearance under standard microscopy often leads to a "diagnostic trap," resulting in either overtreatment or overlooked malignancy.

Methods

Researchers conducted a retrospective analysis of 37 patients diagnosed with GEN-FGMLs at Fujian Provincial Hospital between 2019 and 2023. The study utilized:

  • Histopathology: Review of H&E-stained slides to observe tissue architecture and cellular morphology.
  • Immunohistochemistry (IHC): Analysis of markers including MUC6 and pepsinogen-I (to confirm fundic gland origin) and Ki67 (to measure cell proliferation).
  • Statistical Analysis: Receiver Operating Characteristic (ROC) curves were used to determine optimal diagnostic "cut-off" values for tumor size and Ki67 levels.

Key Clinicopathological Features

The study cohort consisted of 19 OGAs, 16 GA-FGs, and 2 GA-FGMs. The median age of patients was 60 years. Morphologically, these tumors demonstrated well-formed glands with pale, blue-grey columnar cells resembling normal fundic gland cells.

Representative endoscopic and histological images of Oxyntic Gland Adenoma (OGA).

Diagnostic Thresholds

The analysis identified two primary markers for differentiating benign OGA from malignant GA-FG/GA-FGM:

  1. Tumor Size: Lesions larger than 4.5 mm were significantly more likely to be adenocarcinomas ($p < 0.0001$). Larger size also correlated with a higher risk of submucosal invasion.
  2. Ki67 Proliferation Index: While all GEN-FGMLs show low proliferation, a Ki67 index greater than 2.5% served as a strong indicator of adenocarcinoma ($p < 0.0001$).

Biomarker Profile

All cases showed diffuse positivity for MUC6 and pepsinogen-I, confirming their lineage. A notable morphological distinction was found at the surface: while OGAs and GA-FGs are typically covered by normal gastric pit epithelium, GA-FGMs are characterized by dysplastic pit epithelium.

Clinical Outcomes and Prognosis

Despite their classification as adenocarcinomas, GA-FGs and GA-FGMs exhibited favorable biological behavior. During a mean follow-up period of 20.6 months, no cancer-related deaths occurred, and only one patient presented with lymph node metastasis. This suggests that while these tumors are technically malignant, they are relatively indolent.

Conclusion and Future Directions

GEN-FGMLs are a group of well-differentiated gastric tumors with low cellular atypia and favorable outcomes. Accurate diagnosis is critical to avoid overtreatment. Pathologists and endoscopists should utilize tumor size and the Ki67 proliferation index as key diagnostic aids. However, the rarity of these tumors results in small sample sizes, particularly for the GA-FGM subtype. Future multi-center studies are needed to validate the 4.5 mm and 2.5% Ki67 thresholds and explore the underlying molecular drivers, such as GNAS mutations, to better understand the progression from benign adenoma to invasive carcinoma.

Summary updated

Abstract

Background Gastric epithelial neoplasm of the fundic-gland mucosa lineages (GEN-FGMLs) are rare forms of gastric tumors that encompass oxyntic gland adenoma (OGA), gastric adenocarcinoma of the fundic-gland type (GA-FG), and gastric adenocarcinoma of the fundic-gland mucosa type (GA-FGM). There is no consensus on the cause, classification, and clinicopathological features of GEN-FGMLs, and misdiagnosis is common because of similarities in symptoms. Methods 37 cases diagnosed with GEN-FGMLs were included in this study. H&amp;amp;E-stained slides were reviewed and clinicopathological parameters were recorded. Immunohistochemical staining was conducted for MUC2, MUC5AC, MUC6, CD10, CD56, synaptophysin, chromograninA, p53, Ki67, pepsinogen-I, H + /K + -ATPase and Desmin. Results The patients’ ages ranged from 42 to 79 years, with a median age of 60. 17 were male and 20 were female. Morphologically, 19 OGAs, 16 GA-FGs, and two GA-FGMs were identified. Histopathological similarities exist between OGA, GA-FG, and GA-FGM. The tumors demonstrated well-formed glands, expanding with dense growth patterns comprising pale, blue-grey columnar cells with mild nuclear atypia. These cells resembled fundic gland cells. None of the OGA invaded the submucosal layer. The normal gastric pit epithelium covered the entire surface of the OGA and GA-FG, but the dysplasia pit epithelium covered the GA-FGM. Non-atrophic gastritis was observed in more than half of the background mucosa. All cases were diffusely positive for MUC6 and pepsinogen-I on immunohistochemistry. H + /K + -ATPase staining was negative or showed a scattered pattern in most cases. MUC5AC was expressed on the surface of GA-FGMs. p53 was focally expressed and the Ki67 index was low (1%–20%). Compared with OGA, GA-FG and GA-FGM were more prominent in the macroscopic view ( p &amp;lt; 0.05) and had larger sizes ( p &amp;lt; 0.0001). Additionally, GA-FG and GA-FGM exhibited higher Ki67 indices than OGA ( p &amp;lt; 0.0001). Specimens with Ki-67 proliferation indices &amp;gt;2.5% and size &amp;gt;4.5 mm are more likely to be diagnosed with GA-FG and GA-FGM than OGA. Conclusion GEN-FGMLs are group of well-differentiated gastric tumors with favourable biological behaviours, low cellular atypia, and low proliferation. Immunohistochemistry is critical for confirming diagnosis. Compared with OGA, GA-FG and GA-FGM have larger sizes and higher Ki67 proliferation indices, indicating that they play a critical role in the identification of GEN-FGML. Pathologists and endoscopists should be cautious to prevent misdiagnosis and overtreatment, especially in biopsy specimens.
BibTeX
@inproceedings{li2024gastric,
  author = {Houqiang Li and Lanqing Zheng and Guodong Zhong and Xunbin Yu and Xia Zhang and Linying Chen and X Y Chen},
  title = {{Gastric epithelial neoplasm of fundic-gland mucosa lineage: representative of the low atypia differentiated gastric tumor and Ki67 may help in their identification}},
  booktitle = {Pathology},
  year = {2024},
  doi = {10.3389/pore.2024.1611734},
}
Figure